HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health, Beauty And Wellness News: Persona , Mannatech, Thorne, LR

This article was originally published in The Rose Sheet

Executive Summary

New 'Persona' at Vitamin Pack; Mannatech net sales, distributor totals dip; Thorne shares move to Mitsui, Kirin; and LR Health changes CEO.

You may also be interested in...



Vous Vitamin Adds Pregnancy Products To Line Formulated On Customers’ Needs

Vous Vitamin rolls out a pre- and post-natal multivitamin line that factors in diet, lifestyle and pre-pregnancy health. Founders are doctors who say their personalized multivitamins differ from most other customized vitamin lines by delivering nutrition in two pills.

Health, Beauty And Wellness News: Nestle Compleat, FDA Nutrition Strategy

Supplement OWL sports CDX; FDA schedules Nutrition Strategy meeting, improves food substances inventory; Innotech imports Wholy Tea to US; Thorne adds Bommarito to exclusive provider list; and Nestle Compleat line blended for tube-feeding.

US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising

US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121763

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel